Drug Type Recombinant protein |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Motor Neuron Disease | Phase 1 | US | - | |
Multiple Myeloma | Preclinical | KR | 01 Mar 2019 |